+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-11-08Number of Pages: 200

Cardiopulmonary Stress Testing Systems Market (Product Type - Cardiopulmonary Exercise Testing (CPET) Systems, Stress ECG, Pulse Oximeters, Stress Blood Pressure Monitors, Single-Photon Emission Computed Tomography (SPECT); End-user - Hospitals, Specialty Clinics/Cardiology Clinics, Ambulatory Surgical Centers, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Cardiopulmonary Stress Testing Systems Market: Snapshot

Technological innovations remains the focus of established players in the intensely competitive cardiopulmonary stress testing systems market. The market is also facing the emergence of emerging players at an exponential rate that are vying to develop high-value, cost-effective ancillary devices for cardiopulmonary stress testing systems.

Among the several factors driving the global cardiopulmonary stress testing systems market, the significant increase in the adoption of stress testing procedures for early diagnosis of heart diseases is a prominent one. Diagnosis of proper functioning of heart remains the first line of treatment that helps physicians to evaluate the health status of patients that are at risk of cardiovascular diseases.

A report by Transparency Market Research (TMR) estimates the global cardiopulmonary stress testing systems market to clock a CAGR of 4.6% for the forecast period from 2017 to 2025. Proliferating at this pace, the market which stood at US$2.08 bn in 2016 will become worth US$3.08 bn by the end of 2025.

Cardiopulmonary Stress Testing Systems

Product Features and Development of Portable Device Accounts for Dominance of Cardiopulmonary Exercise Testing System

The report studies the global cardiopulmonary stress testing systems market on the basis of product type, end-user, and geography. Based on product type, the global cardiopulmonary stress testing systems market is categorized into cardiopulmonary exercise testing systems, pulse oximeters, stress electrocardiograph, single-photon emission computed tomography, and stress blood pressure monitors. Amongst all, in 2016, the cardiopulmonary exercise testing systems segment led the global cardiopulmonary stress testing systems market vis-à-vis revenue among the various product types. The key reasons for the dominance of the cardiopulmonary exercise testing system is because of a large patient pool with cardiovascular diseases, high average selling price of device, and innovations leading to the development of portable cardiopulmonary exercise testing systems. The cardiopulmonary exercise testing systems segment is likely to continue to dominate this market over the forecast period.

In terms of end-user, the global market for cardiopulmonary stress testing systems is segmented into hospitals, diagnostic centers, ambulatory surgical centers, and specialty clinics/cardiology clinics. Of them, hospitals segment is likely to dominate the global cardiopulmonary stress testing systems market vis-à-vis revenue during the forecast period. The growth of the segment is attributable to factors such as rising preference of physicians as well as patients for the early diagnosis of cardiovascular diseases and extensive research on wireless and portable products. The diagnostic centers segment, on the other hand, is likely to rise at a relatively higher CAGR in terms of value in the global cardiopulmonary stress testing systems market over the forecast period.

Asia Pacific to Emerge Lucrative in Upcoming Years

Based on geography, the global cardiopulmonary stress testing systems market has been classified into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Of them, in 2016, North America held the leading share in the global cardiopulmonary stress testing systems market, and is expected to continue dominance during the forecast period 2017-2025. Rising patient population that demand proper care, increasing adoption of early diagnosis practices, rising adoption of newly introduced advanced systems at public health institutes which aid physicians and nurses to monitor patient’s health in real-time have been some of the key factors responsible for the leading share of North America global cardiopulmonary stress testing systems market.

Asia Pacific is estimated to expand at the leading CAGR in terms of value, among other key regions in the global cardiopulmonary stress testing systems market during the forecast period of 2017-2025.

Leading players in the global cardiopulmonary stress testing systems market include Koninklijke Philips N.V., Hill-Rom Holdings Inc., General Electric Company, MGC Diagnostics Corporation, OSI Systems Inc., Masimo, NIHON KOHDEN CORPORATION, COSMED, Halma pla, Schiller AG, and Vyaire Medical Inc. among others.

Global Cardiopulmonary Stress Testing Systems Market: Snapshot

Technological innovations remains the focus of established players in the intensely competitive cardiopulmonary stress testing systems market. The market is also facing the emergence of emerging players at an exponential rate that are vying to develop high-value, cost-effective ancillary devices for cardiopulmonary stress testing systems.

Among the several factors driving the global cardiopulmonary stress testing systems market, the significant increase in the adoption of stress testing procedures for early diagnosis of heart diseases is a prominent one. Diagnosis of proper functioning of heart remains the first line of treatment that helps physicians to evaluate the health status of patients that are at risk of cardiovascular diseases.

A report by Transparency Market Research (TMR) estimates the global cardiopulmonary stress testing systems market to clock a CAGR of 4.6% for the forecast period from 2017 to 2025. Proliferating at this pace, the market which stood at US$2.08 bn in 2016 will become worth US$3.08 bn by the end of 2025.

Product Features and Development of Portable Device Accounts for Dominance of Cardiopulmonary Exercise Testing System

The report studies the global cardiopulmonary stress testing systems market on the basis of product type, end-user, and geography. Based on product type, the global cardiopulmonary stress testing systems market is categorized into cardiopulmonary exercise testing systems, pulse oximeters, stress electrocardiograph, single-photon emission computed tomography, and stress blood pressure monitors. Amongst all, in 2016, the cardiopulmonary exercise testing systems segment led the global cardiopulmonary stress testing systems market vis-à-vis revenue among the various product types. The key reasons for the dominance of the cardiopulmonary exercise testing system is because of a large patient pool with cardiovascular diseases, high average selling price of device, and innovations leading to the development of portable cardiopulmonary exercise testing systems. The cardiopulmonary exercise testing systems segment is likely to continue to dominate this market over the forecast period.

In terms of end-user, the global market for cardiopulmonary stress testing systems is segmented into hospitals, diagnostic centers, ambulatory surgical centers, and specialty clinics/cardiology clinics. Of them, hospitals segment is likely to dominate the global cardiopulmonary stress testing systems market vis-à-vis revenue during the forecast period. The growth of the segment is attributable to factors such as rising preference of physicians as well as patients for the early diagnosis of cardiovascular diseases and extensive research on wireless and portable products. The diagnostic centers segment, on the other hand, is likely to rise at a relatively higher CAGR in terms of value in the global cardiopulmonary stress testing systems market over the forecast period.

Asia Pacific to Emerge Lucrative in Upcoming Years

Based on geography, the global cardiopulmonary stress testing systems market has been classified into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Of them, in 2016, North America held the leading share in the global cardiopulmonary stress testing systems market, and is expected to continue dominance during the forecast period 2017-2025. Rising patient population that demand proper care, increasing adoption of early diagnosis practices, rising adoption of newly introduced advanced systems at public health institutes which aid physicians and nurses to monitor patient’s health in real-time have been some of the key factors responsible for the leading share of North America global cardiopulmonary stress testing systems market.

Asia Pacific is estimated to expand at the leading CAGR in terms of value, among other key regions in the global cardiopulmonary stress testing systems market during the forecast period of 2017-2025.

Leading players in the global cardiopulmonary stress testing systems market include Koninklijke Philips N.V., Hill-Rom Holdings Inc., General Electric Company, MGC Diagnostics Corporation, OSI Systems Inc., Masimo, NIHON KOHDEN CORPORATION, COSMED, Halma pla, Schiller AG, and Vyaire Medical Inc. among others.

Global Cardiopulmonary Stress Testing Systems: Overview

Global cardiopulmonary stress testing systems market is mainly driven by the rising demand for high value low volume products, and increasing innovations in the new product launches. The market is witnessing growing trend of introduction of wireless devices, and increasing awareness for early diagnosis of cardiovascular diseases is anticipated to steer the global market growth. Significant technological advancement in cardiopulmonary stress testing systems are likely to drive the market growth, and value added service assistance of these devices serves as major opportunity for the players operating in the cardiopulmonary stress testing systems space.

Global Cardiopulmonary Stress Testing Systems: Scope of Study

The market overview section of the report comprises qualitative analysis of the overall cardiopulmonary stress testing systems market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, such as market opportunity analysis for the product type, and end-user, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period which are likely to affect the market dynamics. The applied SWOT analysis has also been provided global cardiopulmonary stress testing systems market. The mortality rate due to cardiovascular diseases has been given for the global cardiopulmonary stress testing systems. The report also covers the regulatory scenario for PMA and CE mark approval of cardiopulmonary stress testing systems.

Global Cardiopulmonary Stress Testing Systems: Market Segmentation

The global cardiopulmonary stress testing systems market is segmented in terms of product type, end-user, and regions. Based on product type, the global cardiopulmonary stress testing systems market is categorized into cardiopulmonary exercise testing systems, pulse oximeters, stress electrocardiograph, stress blood pressure monitors, and single-photon emission computed tomography. The segment cardiopulmonary exercise testing systems is likely to dominate the global cardiopulmonary stress testing systems market during the forecast period. In terms of end-user segment, the global cardiopulmonary stress testing systems market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, and specialty clinics/cardiology clinics.

Geographically, the cardiopulmonary stress testing systems market has been categorized into five regions namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2015 to 2025, in terms of product type, technique, application, and distribution channel, along with the CAGR (%) for the forecast period 2017 to 2025.

Global Cardiopulmonary Stress Testing Systems: Competitive Landscape

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global cardiopulmonary stress testing systems market, in terms of percentage share in 2016 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global cardiopulmonary stress testing systems market such as include Koninklijke Philips N.V., Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.), General Electric Company (GE Healthcare), MGC Diagnostics Corporation, OSI Systems, Inc. (Spacelabs Healthcare), Masimo, NIHON KOHDEN CORPORATION, COSMED, Halma plc (SunTech Medical, Inc.), Schiller AG, and Vyaire Medical, Inc., among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

 The global cardiopulmonary stress testing systems market has been segmented as follows:

  •  Global Cardiopulmonary Stress Testing Systems Market, by Product Type
    • Cardiopulmonary Exercise Testing (CPET) Systems
    • Stress ECG
    • Pulse Oximeters
    • Stress Blood Pressure Monitors
    • Single-Photon Emission Computed Tomography (SPECT)
  • Global Cardiopulmonary Stress Testing Systems Market, by End-user
    • Hospitals
    • Specialty Clinics/Cardiology Clinics
    • Ambulatory Surgical Centers
    • Diagnostic Centers
  • Global Cardiopulmonary Stress Testing Systems Market, by Geography
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa


 
 
Back To Top